This marks the fifth IVL utility patent in the past three years for the company, which earned one last month for its novel next-generation laser-IVL technology.

Minneapolis-based FastWave develops laser-based IVL technology for treating calcific artery disease. Its platform offers durable and fast energy delivery with enhanced sonic output. The system helps to navigate complex arterial anatomy through a high-performing catheter.

FastWave currently has its IVL technology under evaluation in a first-in-human study that kicked off earlier this year.